Kymera Therapeutics, Inc.

KYMR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Oct 1, 2026 4
144 Oct 1, 2026
SCHEDULE 13G/A Sep 8, 2026
4 Sep 4, 2026 4
144 Sep 4, 2026
144 Sep 2, 2026
SCHEDULE 13G/A Aug 14, 2026
SCHEDULE 13G/A Aug 13, 2026
10-Q Aug 5, 2026 10-Q
8-K Aug 5, 2026 8-K
4 Jul 27, 2026 4
3 Jul 27, 2026 3
8-K Jul 27, 2026 8-K
4 Jul 7, 2026 4
144 Jul 7, 2026
4 Jul 2, 2026 4
4 Jul 2, 2026 4
4 Jul 2, 2026 4
4/A Jul 2, 2026
144 Jul 2, 2026
144 Jul 1, 2026
4 Jun 30, 2026
4 Jun 30, 2026
144 Jun 30, 2026
144 Jun 29, 2026
← Newer Page 1 of 26 · 644 filings Older →